WO2015127365A3 - Mutants de sortase a calcium-indépendants - Google Patents

Mutants de sortase a calcium-indépendants Download PDF

Info

Publication number
WO2015127365A3
WO2015127365A3 PCT/US2015/017116 US2015017116W WO2015127365A3 WO 2015127365 A3 WO2015127365 A3 WO 2015127365A3 US 2015017116 W US2015017116 W US 2015017116W WO 2015127365 A3 WO2015127365 A3 WO 2015127365A3
Authority
WO
WIPO (PCT)
Prior art keywords
residue
sortase
calcium
amino acid
mutants
Prior art date
Application number
PCT/US2015/017116
Other languages
English (en)
Other versions
WO2015127365A2 (fr
Inventor
Jessica Ingram
Hidde Ploegh
Original Assignee
Whitehead Institute For Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Institute For Biomedical Research filed Critical Whitehead Institute For Biomedical Research
Publication of WO2015127365A2 publication Critical patent/WO2015127365A2/fr
Publication of WO2015127365A3 publication Critical patent/WO2015127365A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/2207—Sortase A (3.4.22.70)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Cette invention concerne des mutants de sortase A calcium-indépendants manifestant une activité catalytique accrue comparativement à la sortase A de type sauvage.
PCT/US2015/017116 2014-02-21 2015-02-23 Mutants de sortase a calcium-indépendants WO2015127365A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461943042P 2014-02-21 2014-02-21
US61/943,042 2014-02-21

Publications (2)

Publication Number Publication Date
WO2015127365A2 WO2015127365A2 (fr) 2015-08-27
WO2015127365A3 true WO2015127365A3 (fr) 2015-10-15

Family

ID=53879254

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/017116 WO2015127365A2 (fr) 2014-02-21 2015-02-23 Mutants de sortase a calcium-indépendants

Country Status (1)

Country Link
WO (1) WO2015127365A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018005716A2 (fr) * 2016-07-01 2018-01-04 Denali Therapeutics Inc. Variants de l'albumine pour une demi-vie sérique améliorée
EP4196590A4 (fr) * 2021-01-28 2023-12-06 Genequantum Healthcare (Suzhou) Co., Ltd. Protéines de fusion de ligase et applications associées

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6773706B2 (en) * 1999-04-15 2004-08-10 The Regents Of The University Of California Identification of sortase gene
WO2013016653A1 (fr) * 2011-07-28 2013-01-31 Cell Signaling Technology, Inc. Détection multi-composants

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6773706B2 (en) * 1999-04-15 2004-08-10 The Regents Of The University Of California Identification of sortase gene
WO2013016653A1 (fr) * 2011-07-28 2013-01-31 Cell Signaling Technology, Inc. Détection multi-composants

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE NCBI, Genbank 17 November 2009 (2009-11-17), "Staphylococcus aureus subsp. aureus ED98", XP055231327, Database accession no. ACY12423 *
HIRAKAWA ET AL.: "Design of Ca2+-independent Staphylococcus aureus sortase A mutants", BIOTECHNOLOGY AND BIOENGINEERING, vol. 109, no. 12, 4 July 2012 (2012-07-04), pages 2955 - 2961, XP055210375 *
LOWDER ET AL.: "Recent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 106, no. 46, 17 November 2009 (2009-11-17), pages 19545 - 19550, XP055039038 *
MARESSO ET AL.: "Sortase as a Target of Anti-Infective Therapy", PHARMACOLOGICAL REVIEWS, vol. 60, no. 1, 2008, pages 128 - 141, XP055231326 *

Also Published As

Publication number Publication date
WO2015127365A2 (fr) 2015-08-27

Similar Documents

Publication Publication Date Title
WO2018191715A3 (fr) Polypeptides à activité crispr de type v et leurs usages
PH12018501355A1 (en) Rsv f protein mutants
PH12016501813B1 (en) 1,3-benzodioxole derivative
MY186296A (en) Novel promoter and use thereof
WO2016203064A3 (fr) Composition de détergent comprenant des variants de protéase et d'amylase
MX2018005829A (es) Composiciones para tratar el cabello.
WO2015183890A3 (fr) Méthodes et compositions pour le traitement de maladies et de troubles métaboliques
WO2016130600A9 (fr) Compositions et procédés pour l'édition de l'épigénome
PH12017500785A1 (en) INTERFERON a2B VARIANTS
EP4296278A3 (fr) Animaux non humains ayant un groupe humanisé de gène de différenciation 47
MY160995A (en) Polypeptides with permease activity
WO2016193351A3 (fr) Micro-organisme recombinant pour la production améliorée de produits chimiques fins
WO2015019198A3 (fr) Compositions pharmaceutiques de pancréatine de puissance élevée
WO2015181119A3 (fr) Variants lipasiques et polynucléotides codant pour ceux-ci
WO2017011340A3 (fr) Protéines et compositions immunisantes contenant des protéines de klebsiella et leurs procédés d'utilisation
MX2021013879A (es) Variantes de lipasa y polinucleotidos que las codifican.
WO2017017673A3 (fr) Protéines stables et procédés pour leur conception
PH12016501689B1 (en) Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof
MY189160A (en) Compositions and methods for treating celiac sprue disease
WO2015185758A3 (fr) Préparation comprenant le facteur viii et des peptides du facteur de von willebrand
WO2018004224A3 (fr) Nouveau microorganisme appartenant à la famille des sporichthyaceae et son utilisation
WO2017060318A3 (fr) Hydroxylases de l'acide kaurénoïque
MX2017007503A (es) Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa.
WO2015127365A3 (fr) Mutants de sortase a calcium-indépendants
WO2016134145A3 (fr) Cytochromes p450 autosuffisants artificiels

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15751497

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15751497

Country of ref document: EP

Kind code of ref document: A2